409 related articles for article (PubMed ID: 27855717)
1. Hypertension control and care at Mulago Hospital ambulatory clinic, Kampala-Uganda.
Ssinabulya I; Nabunnya Y; Kiggundu B; Musoke C; Mungoma M; Kayima J
BMC Res Notes; 2016 Nov; 9(1):487. PubMed ID: 27855717
[TBL] [Abstract][Full Text] [Related]
2. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
3. Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria.
Adejumo O; Okaka E; Iyawe I
Malawi Med J; 2017 Jun; 29(2):113-117. PubMed ID: 28955417
[TBL] [Abstract][Full Text] [Related]
4. Treating essential hypertension. The first choice is usually a thiazide diuretic.
Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
[TBL] [Abstract][Full Text] [Related]
5. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
6. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
[TBL] [Abstract][Full Text] [Related]
9. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
Brown A; Captain B
Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
[TBL] [Abstract][Full Text] [Related]
10. A review of chemical therapies for treating diabetic hypertension.
Sarafidis PA; Alexandrou ME; Ruilope LM
Expert Opin Pharmacother; 2017 Jun; 18(9):909-923. PubMed ID: 28480805
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
12. Managing Hypertension Using Combination Therapy.
Smith DK; Lennon RP; Carlsgaard PB
Am Fam Physician; 2020 Mar; 101(6):341-349. PubMed ID: 32163253
[TBL] [Abstract][Full Text] [Related]
13. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
Antza C; Stabouli S; Kotsis V
Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
[TBL] [Abstract][Full Text] [Related]
16. [Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology].
Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM
Presse Med; 2014 Dec; 43(12 Pt 1):1325-31. PubMed ID: 25459067
[TBL] [Abstract][Full Text] [Related]
17. Management of hypertension in patients with CKD: differences between primary and tertiary care settings.
Minutolo R; De Nicola L; Zamboli P; Chiodini P; Signoriello G; Toderico C; Arfè G; Boschi G; Brancati C; Iaccarino P; Conte G
Am J Kidney Dis; 2005 Jul; 46(1):18-25. PubMed ID: 15983953
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
[TBL] [Abstract][Full Text] [Related]
20. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.
Volpe M; Tocci G; de la Sierra A; Kreutz R; Laurent S; Manolis AJ; Tsioufis K
High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):463-472. PubMed ID: 29086364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
